Cargando…

Proton stereotactic body radiation therapy for non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Diwanji, Tejan, Sawant, Amit, Sio, Terence T., Patel, Nirav V., Mohindra, Pranshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576051/ https://www.ncbi.nlm.nih.gov/pubmed/33241047 http://dx.doi.org/10.21037/atm-20-2975

Ejemplares similares

Advances in proton therapy in lung cancer
por: Vyfhuis, Melissa A.L., et al.
Publicado: (2018)

Surgery for early-stage small cell lung cancer: is it worth it?
por: Vyfhuis, Melissa A. L., et al.
Publicado: (2019)

Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults
por: Diwanji, Tejan P, et al.
Publicado: (2017)

Radiation therapy considerations during the COVID‐19 Pandemic: Literature review and expert opinions
por: Mohindra, Pranshu, et al.
Publicado: (2020)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
por: Alite, Fiori, et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Commentary: Stereotactic body radiation therapy versus surgery for stage I non–small cell lung cancer in healthy patients: Not quite there yet
por: Sideris, Antonios, et al.
Publicado: (2022)

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed
por: Shen, James L., et al.
Publicado: (2022)

Is there a role for stereotactic body radiation before immune checkpoint inhibitor therapy for advanced hepatocellular carcinoma?
por: Mukherjee, Sandeep
Publicado: (2023)

Commentary: The debate between surgery and stereotactic body radiation therapy in treatment of early non–small cell lung cancer: A new connotation is needed for an old topic
por: Chen, Ke-Neng
Publicado: (2021)

A biologically effective dose threshold for stereotactic body radiation therapy—can we put the issue to BED?
por: Mix, Michael, et al.
Publicado: (2020)

Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early‐stage NSCLC patients with SBRT
por: Mohindra, Pranshu, et al.
Publicado: (2019)

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Three discipline collaborative radiation therapy (3DCRT) special debate: FLASH radiotherapy needs ongoing basic and animal research before implementing it to a large clinical scale
por: Guerrieri, Patrizia, et al.
Publicado: (2022)

Stereotactic body radiation therapy for non-small cell lung cancer: A review
por: Prezzano, Kavitha M, et al.
Publicado: (2019)

Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020)

Dramatic Response of a Large, 10 Cm Hepatocellular Carcinoma to Monotherapy with Yttrium-90 Based Selective Internal Radiation Therapy
por: Diwanji, Tejan, et al.
Publicado: (2015)

Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
por: Kim, Nalee, et al.
Publicado: (2022)

Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2022)

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
por: Siva, Shankar, et al.
Publicado: (2016)

Dramatic Response of an Aggressive Chest Wall Recurrence to Hyperthermia, Radiation, and Chemotherapy
por: Cohen, Justin, et al.
Publicado: (2017)

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer
por: Bae, Bong Kyung, et al.
Publicado: (2022)

Reproducibility of a novel, vacuum‐assisted immobilization for breast stereotactic radiotherapy
por: Snider, James W., et al.
Publicado: (2021)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Quality Assurance and Commissioning of an Infrared Marker-Based Patient Positioning System for Frameless Extracranial Stereotactic Radiotherapy
por: Gupta, Tejpal, et al.
Publicado: (2007)

Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer
por: Kim, Daniel W., et al.
Publicado: (2019)

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
por: Rico, Mikel, et al.
Publicado: (2021)

Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer
por: Kocak Uzel, Esengul, et al.
Publicado: (2023)

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple “MIRAGE”?
por: Bosetti, Davide Giovanni, et al.
Publicado: (2023)

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study
por: Guo, Yanling, et al.
Publicado: (2023)

Stereotactic body radiation therapy for pancreatic cancer: a potential ally in the era of immunotherapy?
por: Park, Jin-hong
Publicado: (2022)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Impact of tissue heterogeneity corrections in stereotactic body radiation therapy treatment plans for lung cancer
por: Herman, Tania De La Fuente, et al.
Publicado: (2010)

Open surgery for ventricular tachycardia following failed stereotactic radiation treatment: A bailout when a parachute hasn’t helped
por: Futyma, Piotr, et al.
Publicado: (2021)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

The role of technology in clinical trials using stereotactic body radiotherapy
por: Aznar, Marianne, et al.
Publicado: (2017)

Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations
por: Herman, Tania De La Fuente, et al.
Publicado: (2010)

Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs
por: Damen, Pim J. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l3nlmkrejvglhe65djfanv3n7l